Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-02

Clinical Trial Update: Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the efficacy and safety of an arformoterol and tiotropium combination versus each therapy alone in chronic obstructive pulmonary disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • arformoterol (arformoterol)
  • tiotropium (tiotropium)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Chronic Obstructive Pulmonary Disease, Bronchitis | Phase 4 | Status: COMPLETED | Results posted: 2009-04-02